Trademark Overview
On Thursday, June 15, 2023, a trademark application was filed for ACEPODIA with the United States Patent and Trademark Office. The USPTO has given the ACEPODIA trademark a serial number of 98044266. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, March 11, 2024. This trademark is owned by Acepodia Biotechnologies Ltd.. The ACEPODIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Design and testing for new cell product development, namely, natural killer cell, gamma delta T cell, stem cell, or other cell product development; Platform as a service (PAAS) to develop cell products to improve ability to target tumor cells or other abnormal cells; Platform as a service (PAAS) for use with cell therapy to manufacture tumor targeted or abnormal cell targeted cell products for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease; Providing information of cells and cell-derived preparations; Providing products for use in the fields of cell therapy and regenerative medicine services
